Assessing inflammatory bowel disease-associated antibodies in Caucasian and First Nations cohorts

Canadian Journal of Gastroenterology

Volumn 25, Issue 5, 2011, Pages 269-273

  Bernstein, Charles N ^a   El Gabalawy, Hani ^a   Sargent, Michael ^a   Landers, Carol J ^b   Rawsthorne, Patricia ^a   Elias, Brenda ^a   Targan, Stephan R ^b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Antibodies; Crohn's disease; Ethnicity; Inflammatory bowel disease; Rheumatoid arthritis; Ulcerative colitis

Indexed keywords

BACTERIAL DNA; DNA ANTIBODY; FLAGELLIN; FLAGELLIN CBIR 1; FUNGUS ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; NEUTROPHIL CYTOPLASMIC ANTIBODY; OUTER MEMBRANE PROTEIN C; SACCHAROMYCES CEREVISIAE ANTIBODY; UNCLASSIFIED DRUG; AUTOANTIBODY; IMMUNOLOGIC FACTOR;

ADULT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CAUCASIAN; CHRONIC DISEASE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; CROHN DISEASE; ESCHERICHIA COLI; FEMALE; HUMAN; IMMUNOPATHOLOGY; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; PSEUDOMONAS FLUORESCENS; RACE DIFFERENCE; RHEUMATOID ARTHRITIS; SACCHAROMYCES CEREVISIAE; ULCERATIVE COLITIS; AMERICAN INDIAN; ANTIBODY SPECIFICITY; BLOOD; ENZYME LINKED IMMUNOSORBENT ASSAY; ETHNOLOGY; IMMUNOLOGY;

ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTIBODIES, FUNGAL; ANTIBODY SPECIFICITY; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; COLITIS, ULCERATIVE; CROHN DISEASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; IMMUNOLOGIC FACTORS; INDIANS, NORTH AMERICAN; SACCHAROMYCES CEREVISIAE;

EID: 79959811829     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2011/712350     Document Type: Article

References (55)

1. Bernstein CN, Wajda A, Blanchard JF, et al. The burden of IBD in Canada: A population-based study. Am J Gastroenterol 2006;101:1559-68.
2. Bernstein CN, Blanchard JF, Rawsthorne P, Wajda A. The epidemiology of Crohn's disease and ulcerative colitis in a central Canadian province: A population-based study. Am J Epidemiol 1999;149:916-24. (Pubitemid 29230706)
3. Lowe AM, Roy PO, B-Poulin M, et al. Epidemiology of Crohn's disease in Québec, Canada. Inflamm Bowel Dis 2009;15:429-35.
4. Benchimol EI, Guttman A, Griffiths AM, et al. Increasing incidence of paediatric inflammatory bowel disease in Ontario, Canada: Evidence from health administrative data. Gut 2009;58:1490-7.
5. Blanchard JF, Bernstein CN, Wajda A, Rawsthorne P. Small-area variations and sociodemographic correlates for the incidence of Crohn's disease and ulcerative colitis. Am J Epidemiol 2001;154:328-35. (Pubitemid 32756629)
6. Green C, Elliott L, Beaudoin C, Bernstein CN. An ecological population-based study of IBD: Searching for etiological clues. Am J Epidemiol 2006;164:615-23. (Pubitemid 44453488)
7. Bernstein CN, Shanahan F. Disorders of a modern lifestyle - reconciling the epidemiology of inflammatory bowel diseases. Gut 2008;57:1185-91.
8. Woods RJ, Rothschild BM. Population analysis of symmetrical erosive arthritis in Ohio Woodland Indians (1200 years ago). J Rheumatol 1988;15:1258-63.
9. Rothschild BM, Turner KR, DeLuca MA. Symmetrical erosive peripheral polyarthritis in the late archaic period of Alabama. Science 1988;241:1498-501.
10. Rothschild BM, Woods RJ. Symmetrical erosive disease in Archaic Indians: The origin of rheumatoid arthritis in the New World? Semin Arthritis Rheum 1990;19:278-84. (Pubitemid 20150819)
11. Engel A, Roberts J, Burch TA. Rheumatoid arthritis in adults. Vital Health Stat 1 1966;11:1-43.
12. Linos A, Worthington JW, O'Fallon WM, Kurland LT. The epidemiology of rheumatoid arthritis in Rochester, Minnesota: A study of incidence, prevalence, and mortality. Am J Epidemiol 1980;111:87-98. (Pubitemid 10207608)
13. Harvey J, Lotze M, Stevens MB, et al. Rheumatoid arthritis in a Chippewa Band. I. Pilot screening study of disease prevalence. Arthritis Rheum 1981;24:717-21. (Pubitemid 11099289)
14. Brien WM, Bennett PH, Burch TA, Bunim JJ. A genetic study of rheumatoid arthritis and rheumatoid factor in Blackfeet and Pima Indians. Arthritis Rheum 1967;10:163-79.
15. Willkens RF, Blandau RL, Aoyama DT, Beasley RP. Studies of rheumatoid arthritis among a tribe of Northwest Indians. J Rheumatol 1976;3:9-14.
16. Boyer GS, Templin DW, Lanier AP. Rheumatic diseases in Alaskan Indians of the southeast coast: High prevalence of rheumatoid arthritis and systemic lupus erythematosus. J Rheumatol 1991;18:1477-84.
17. Peschken CA, El-Gabalawy HS, Roos LL, Esdaile JM. Algonkian Indians have twice the frequency of rheumatoid arthritis with a younger age of onset. Arthritis Rheum 1998;41:S558.
18. Sartor RB. Microbial influences in inflammatory bowel diseases. Gastroenterology 2008;134:577-94. (Pubitemid 351173057)
19. Tamboli CP, Neut C, Desreumaux P, Colombel JF. Dysbiosis in inflammatory bowel disease. Gut 2004;53:1-4. (Pubitemid 38082999)
20. Sutton CL, Yang H, Li Z, et al. Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in affected and unaffected relatives of patients with Crohn's disease. Gut 2000;46:58-63. (Pubitemid 30307678)
21. Sutton CL, Kim J, Yamane A, et al. Identification of a novel bacterial sequence associated with Crohn's disease. Gastroenterology 2000;119:23-31. (Pubitemid 30452575)
22. Landers C, Cohavy O, Misra R et al. Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto- and microbial antigens. Gastroenterology 2002;123:689-99. (Pubitemid 34977074)
23. Targan SR, Landers CJ, Yang H, et al. Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease. Gastroenterology 2005;128:2020-8. (Pubitemid 40824710)
24. Lodes MJ, Cong Y, Elson CO, et al. Bacterial flagellin is a dominant antigen in Crohn's disease. J Clin Invest 2004;113:1296-306. (Pubitemid 39069929)
25. Rutgeerts P, Vermeire S. Clinical value of the detection of antibodies in the serum for diagnosis and treatment of inflammatory bowel disease. Gastroenterology 1998;115:1006-8.
26. Amre DK, Lu SE, Costea F, Seidman EG. Utility of serological markers in predicting the early occurrence of complications and surgery in pediatric Crohn's disease patients. Am J Gastroenterol 2006;101:645-52. (Pubitemid 43340944)
27. Ruemmele FM, Targan SR, Levy G, et al. Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease. Gastroenterology 1998;115:822-9. (Pubitemid 28452928)
28. Vasiliauskas, EA, Kam, LY, Karp, LC, et al. Marker antibody expression stratifies Crohn's disease into immunologically homogeneous subgroups with distinct clinical characteristics. Gut 2000;47:487-96.
29. Desir B, Amre DK, Lu SE, et al. Utility of serum antibodies in determining clinical course in pediatric Crohn's disease. Clin Gastroenterol Hepatol 2004;2:139-46. (Pubitemid 38180468)
30. Walker LJ, Aldhous, MC, Drummond, HE, et al. Anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease are associated with disease severity but not NOD2/CARD15 mutations. Clin Exp Immunol 2004;135:490-6. (Pubitemid 38297152)
31. Mow WS, Vasiliauskas EA, Lin Y-C, et al. Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease. Gastroenterology 2004;126:414-24. (Pubitemid 38182298)
32. Forcione DG, Rosen MJ, Kisiel JB, et al. Anti-Saccaromyces cerevisiae antibody (ASCA) positivity is associated with increased risk for early surgery in Crohn's disease. Gut 2004;53:1117-22. (Pubitemid 38961964)
33. Zholudev A, Zurakowski D, Young W, et al. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: Diagnostic value and correlation with disease phenotype. Am J Gastroenterol 2004;99:2235-41. (Pubitemid 39524716)
34. Fleshner P, Ippoliti A, Dubinsky M, et al. Both preoperative perinuclear antineutrophil cytoplasmic antibody and anti-CBir1 expression in ulcerative colitis patients influence pouchitis development after ileal pouch-anal anastomosis. Clin Gastroenterol Hepatol 2008;6:561-8.
35. Sandborn WJ, Loftus EV Jr, Colombel JF, et al. Evaluation of serologic disease markers in a population-based cohort of patients with ulcerative colitis and Crohn's disease. Inflamm Bowel Dis 2001;7:192-201. (Pubitemid 32776511)
36. Peeters M, Joosens S, Vermeire S, et al. Diagnostic value of anti-Saccharomyces cerivisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease. Am J Gastroenterol 2001;96:730-4. (Pubitemid 32240723)
37. Duerr RH, Targan SR, Landers CJ, et al. Anti-neutrophil cytoplasmic antibodies in ulcerative colitis. Comparison with other colitides/diarrheal illnesses. Gastroenterology 1991;100:1590-6.
38. Annese V, Andreoli A, Andriulli A, et al. Familial expression of anti-Saccharomyces cerevisiae Mannan antibodies in Crohn's disease and ulcerative colitis: A GISC study. Am J Gastroenterol 2001;96:2407-12. (Pubitemid 32769203)
39. Quinton JF, Sendid B, Reumaux D, et al. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: Prevalence and diagnostic role. Gut 1998;42:788-91. (Pubitemid 28277217)
40. Larcombe L, Rempel JD, Dembinsli I, et al. Differential cytokine genotype frequencies among Canadian Aboriginal and Caucasian populations. Genes Immunity 2005;6:140-4. (Pubitemid 40439540)
41. Larcombe LA, Orr PH, Lodge AM, et al. Functional gene polymorphisms in Canadian Aboriginal populations with high rates of tuberculosis. J Infect Dis 2008;198:1175-9.
42. Seibold F, Brandwein S, Simpson S, et al. pANCA represents a cross-reactivity to enteric bacterial antigens. J Clin Immunol 1998;18:153-8.
43. Eggena M, Cohavy O, Parseghian MH, et al. Identification of histone H1 as a cognate antigen of the ulcerative colitis-associated marker antibody pANCA. J Autoimmun 2000;14:83-97. (Pubitemid 30080541)
44. Bernstein CN, Mckeown I, Embil JM, et al. Seroprevalence of Helicobacter pylori, and incidence of gastric cancer and peptic ulcer associated hospitalizations, in a Canadian Indian population. Dig Dis Sci 1999;44:668-74. (Pubitemid 29186307)
45. Sinha SK, Martin B, Gold BD, et al. The incidence of Helicobacter pylori acquisition in children of a Canadian First Nations community: And the potential for parent-to-child-transmission. Helicobacter 2004;9:59-68. (Pubitemid 38250068)
46. Schanfield MS. Immunoglobulin allotypes indicate multiple founding populations of Native Americans: Evidence of at least four migrations to the New World. Hum Biol 1992;64:381-402.
47. Weiss KM. American origins. Proc Natl Acad Sci USA 1994;91:833-5. (Pubitemid 24048460)
48. Torroni A, Neel JV, Barrantes R, Schurr TG, Wallace DC. Mitochondrial DNA "clock" for the Amerinds and its implications for timing their entry into North America. Proc Natl Acad Sci USA 1994;91:1158-62.
49. Nowak MP, Tyndale RF, Sellers EM. CYP2D6 phenotype and genotype in a Canadian Native Indian population. Pharmacogenetics 1997;7:145-8. (Pubitemid 27261847)
50. Nowak MP, Sellers EM, Tyndale RF. Canadian Native Indians exhibit unique CYP2A6 and CYP2C19 mutant allele frequencies. Clin Pharmacol Ther 1998;64:378-83. (Pubitemid 28473763)
51. Brown MD, Hosseini SH, Torroni A, et al. mtDNA haplogroup X: An ancient link between Europe/Western Asia and North America? Am J Hum Genet 1998;63:1852-61. (Pubitemid 30415747)
52. Lawrance IC, Murray K, Hall A, Sung JJ, Leong R. A prospective comparative study of ASCA and pANCA in Chinese and Caucasian IBD patients. Am J Gastroenterol 2004;99:2186-94. (Pubitemid 39524710)
53. Lee JH, Cheon JH, Kim ES, et al. The prevalence and clinical significance of perinuclear anti-neutrophil cytoplasmic antibody in Korean patients with ulcerative colitis. Dig Dis Sci 2010;55:1406-12.
54. Vermeire S, Peeters M, Vlietinck R et al. Anti-Saccharomyces cerivisiae antibodies (ASCA), phenotypes of IBD, and intestinal permeability: A study in IBD families. Inflamm Bowel Dis 2001;7:8-15.
55. Ling M, Targan SR, Landers CJ, et al. Familial expression of anti Escherichia coli outer membrane porin C in relatives of patients with Crohn's disease. Gastroenterology 2006;130:1076-85.